By Argus. As you age, cells that should have died instead linger — refusing to divide, refusing to die, and spewing a toxic broth of inflammatory signals into the tissue around them. A new class of drugs hunts these 'zombie' cells down and kills them. Here's the biology, the SASP mechanism, and what the first human trials in frailty, lung fibrosis, and kidney disease actually show in 2026.